Pregnancy in Sickle Cell Disease Is a Very High-Risk Situation: An Observational Study
Table 5
Comparison of maternal-fetal characteristics between transfused and nontransfused pregnant women with sickle cell disease during pregnancy.
Nontransfused ()
Transfused ()
Median age (years)
25.9 (16–40)
26 (17–41)
0.7
Pregestational Hb (g/dL)
9.9 (8.4–11.4)
8.7 (7.1–10.7)
0.06
Abnormal fetal heart rate (%)
6 ()
3 ()
0.4
Preterm labor (%)
4 ()
3 ()
0.3
Preeclampsia (%)
5 ()
6 ()
0.8
Fetal death in utero (%)
1 ()
2 ()
0.5
Intrauterine growth retardation (%)
8 (24.2)
7 (24.1)
0.9
Maternal hospitalization in ICU (%)
5 ()
5 ()
0.8
Maternal death (%)
0
0
Total death (maternal and fetal) (%)
0
0
Prematurity (%)
6 ()
12 (41)
0.04
We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.
